Medicaid beneficiaries in treatment for opioid use disorder (OUD) who take buprenorphine for at least 15 months have better outcomes than people who discontinue buprenorphine treatment after six to nine months. Those with the longer treatment duration have 52% lower relative risk of an inpatient hospitalization for any reason. Longer treatment durations were also associated with 26% lower relative risk of an emergency department visit.

A National Quality Forum-endorsed measure supports OUD treatment lasting at least 180 days. In addition to lower risk of all-cause hospitalization and emergency department visits among those who continued on buprenorphine maintenance treatment . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

The News

Daily coverage of the developments shaping health and human services. From policy shifts to program innovations, reports on trends-shaping mental health, addiction treatment, child and family services, autism and I/DD, disability support and long-term care, social services, corrections, juvenile justice, chronic disease management, health care systems, and more-helping leaders make timely, informed decisions.

Filter Options

  • By Market
  • By Topic
  • By Date Range
  • Sort Date By
  • Results Per Page
Clear Filters